Your browser doesn't support javascript.
loading
Anaphylactic Shock Due to Technetium (99mTc)-Tetrofosmin During Myocardial Perfusion Scintigraphy: A Case Report.
Hashimoto, Sho; Tanaka, Tetsuya; Shimoda, Yoshiaki; Tanaka, Mariko; Kondo, Morihiko.
Afiliación
  • Hashimoto S; Cardiology, Japan Community Healthcare Organization (JCHO) Kobe Central Hospital, Kobe, JPN.
  • Tanaka T; Cardiology, Japan Community Healthcare Organization (JCHO) Kobe Central Hospital, Kobe, JPN.
  • Shimoda Y; Cardiology, Japan Community Healthcare Organization (JCHO) Kobe Central Hospital, Kobe, JPN.
  • Tanaka M; Cardiology, Japan Community Healthcare Organization (JCHO) Kobe Central Hospital, Kobe, JPN.
  • Kondo M; Cardiology, Japan Community Healthcare Organization (JCHO) Kobe Central Hospital, Kobe, JPN.
Cureus ; 16(1): e52644, 2024 Jan.
Article en En | MEDLINE | ID: mdl-38380212
ABSTRACT
Myocardial perfusion scintigraphy is a popular minimally invasive method for evaluating chronic coronary disease (CCD). We performed myocardial scintigraphy to assess CCD in a 74-year-old man with a history of allergy to contrast media. The patient developed anaphylactic shock immediately after the administration of the technetium (99mTc)-tetrofosmin preparation. This is the first report of anaphylactic shock due to 99mTc-tetrofosmin administration during myocardial perfusion scintigraphy.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos